Unichem Laboratories surged 8.17% to Rs 219.15 at 09:21 IST on BSE after the company said it has received establishment inspection report for post marketing adverse drug experience inspection from the US drug regulator.
The announcement was made after market hours yesterday, 26 November 2018.Meanwhile, the S&P BSE Sensex was down 32.55 points, or 0.09% to 35,321.53
On the BSE, 33,000 shares were traded in the counter so far compared with average daily volumes of 3,575 shares in the past two weeks. The stock had hit a high of Rs 224.55 and a low of Rs 215.70 so far during the day. The stock hit a record high of Rs 382 on 8 January 2018. The stock hit a 52-week low of Rs 182 on 11 October 2018.
Unichem Laboratories said that the company has received establishment inspection report (EIR) for post marketing adverse drug experience inspection conducted by the USFDA from 25-29 June 2018, indicating closure of inspection.
Unichem Laboratories' net profit dropped 66.8% to Rs 15.21 crore on 12.74% rise in total income to Rs 278.50 crore in Q2 September 2018 over Q2 September 2017.
Unichem Laboratories is a pharmaceutical company.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
